Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection-Reference-Cited by-同舟云学术

Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection

Published:2022-10-06 Issue:14 Volume:387 Page:1333-1336
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Havervall Sebastian^ORCID,Marking Ulrika,Svensson Julia,Greilert-Norin Nina,Bacchus Philip¹^ORCID,Nilsson Peter,Hober Sophia,Gordon Max²,Blom Kim,Klingström Jonas^ORCID,Åberg Mikael³,Smed-Sörensen Anna,Thålin Charlotte

Affiliation:

1. Swedish Armed Forces, Umeå, Sweden

2. Karolinska Institutet, Stockholm, Sweden

3. Uppsala University, Uppsala, Sweden

Funder

Region Stockholm

Center for Innovative Medicine

Bill and Melinda Gates Foundation

Vetenskapsrådet

Hjärt-Lungfonden

Knut och Alice Wallenbergs Stiftelse

Jonas & Christina af Jochnick Foundation

Leif Lundblad Family Foundation

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMc2209651

Reference5 articles.

1. Mucosal Vaccines, Sterilizing Immunity, and the Future of SARS-CoV-2 Virulence

2. Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination

3. Potent human broadly SARS-CoV-2–neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2

4. Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection

5. Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment;Vaccine;2024-11

2. Robust immune response to COVID-19 vaccination in the island population of Greenland;Communications Medicine;2024-09-06

3. Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates;Nature Immunology;2024-09-03

4. Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters;Frontiers in Immunology;2024-08-30

5. MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses;Frontiers in Immunology;2024-08-29